Egnite is highlighting study results of a new artificial intelligence (AI) algorithm for predicting aortic stenosis severity at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 conference held November 4-6 in Orlando, FL.
The company's Disease Progression algorithm was designed to predict the likelihood a patient with moderate aortic stenosis would later be diagnosed with severe stenosis over a one- and two-year period. The software can help physicians identify and prioritize the review of patients with moderate aortic stenosis who are at higher risk of progressing to severe disease, the company said.
Researchers analyzed 719,321 echo exams and found the algorithm was able to successfully predict progression rates for patients with an average error rate of 3.1%.
The algorithm is part of egnite's CardioCare platform, the company's flagship product, which first launched with a suite of predictive algorithms in May 2021.
